# Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study

> **NCT01212731** · — · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 60 (actual)

## Conditions studied

- Malignancy
- Glioma
- Radiotherapy

## Interventions

- **RADIATION:** Photon treatment plans
- **RADIATION:** Proton Treatment Plans
- **BEHAVIORAL:** Neurocognitive evaluation
- **DEVICE:** Advanced MRI imaging

## Key facts

- **NCT ID:** NCT01212731
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2015-08-31
- **Final completion:** 2017-10-17
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01212731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01212731, "Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01212731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*